DC4 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dexcom Inc

Watchlist Manager

Watchlist

Price: 75.6 EUR -1.82%

Market Cap: €30.1B

D	Dexcom Inc F:DC4	US
M	Mega Lifesciences PCL SET:MEGA	TH
	Element Fleet Management Corp F:61F	CA
B	Bank of America Corp F:NCB	US

Profitability Summary

Dexcom Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

64%

Strong 3Y Average Gross Margin

62%

Declining Gross Margin

64% > 64%

Healthy Operating Margin

23%

Sustainable 3Y Average Operating Margin

18%

Operating Margin is Increasing

14% > 23%

Healthy Net Margin

20%

Sustainable 3Y Average Net Margin

16%

Net Margin is Increasing

11% > 20%

Exceptional Free Cash Flow Margin

28%

Strong 3Y Average Free Cash Flow Margin

18%

Free Cash Flow Margin is Increasing

15% > 28%

Exceptional ROE

38%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

18%

ROIC is Increasing

12% > 22%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.